The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibodies for Research Market Research Report 2024
Synopsis
Research antibodies are divided into monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies, also called mAbs, are laboratory-made antibodies that bind to specific targets in the body, such as antigens on the surface of cancer cells. There are several types of monoclonal antibodies, and each mAb is designed to bind a single antigen. They can be used alone or in combination with other drugs to deliver drugs, toxins or radioactive substances directly to cancer cells.
Polyclonal antibody, also known as "polyclonal antibody" (Polyclonal Antibody), is an antibody mixture containing multiple types of antibodies. The "poly" in its name refers to the mixture of antibodies produced by different types of plasma cells.
Global Antibodies for Research market is projected to reach US$ 2067.4 million in 2029, increasing from US$ 1479.1 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antibodies for Research market research.
Rising R&D activities in neurological, oncology, and stem cell research, increasing prevalence of cancer and infectious diseases, growing demand for antibodies, and increasing regulation across the biopharmaceutical industry are the key factors driving the research-based antibodies market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antibodies for Research market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Johnson and Johnson Services
Eli Lilly and Company
Bio-Rad Laboratories, Inc
Cell Signalling Technology
PerkinEImer
Rockland Immunochemicals
Novartis
BD
Abcam
Kamiya Biomedical
AMSBIO
Thermo Fisher Scientific
GeneTex
MCE
Shanghai Yanmai Biotechnology
Shanghai LONG ISLAND Antibody Diagnostica
SUNSHINE GUOJIAN PHARMACEUTICAL
Shanghai Junshi Biosciences
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Oncology
Neurobiology
Immunology
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Antibodies for Research report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Research antibodies are divided into monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies, also called mAbs, are laboratory-made antibodies that bind to specific targets in the body, such as antigens on the surface of cancer cells. There are several types of monoclonal antibodies, and each mAb is designed to bind a single antigen. They can be used alone or in combination with other drugs to deliver drugs, toxins or radioactive substances directly to cancer cells.
Polyclonal antibody, also known as "polyclonal antibody" (Polyclonal Antibody), is an antibody mixture containing multiple types of antibodies. The "poly" in its name refers to the mixture of antibodies produced by different types of plasma cells.
Global Antibodies for Research market is projected to reach US$ 2067.4 million in 2029, increasing from US$ 1479.1 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Antibodies for Research market research.
Rising R&D activities in neurological, oncology, and stem cell research, increasing prevalence of cancer and infectious diseases, growing demand for antibodies, and increasing regulation across the biopharmaceutical industry are the key factors driving the research-based antibodies market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Antibodies for Research market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck
Johnson and Johnson Services
Eli Lilly and Company
Bio-Rad Laboratories, Inc
Cell Signalling Technology
PerkinEImer
Rockland Immunochemicals
Novartis
BD
Abcam
Kamiya Biomedical
AMSBIO
Thermo Fisher Scientific
GeneTex
MCE
Shanghai Yanmai Biotechnology
Shanghai LONG ISLAND Antibody Diagnostica
SUNSHINE GUOJIAN PHARMACEUTICAL
Shanghai Junshi Biosciences
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Oncology
Neurobiology
Immunology
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Antibodies for Research report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Antibodies for Research Market Overview
1.1 Product Overview and Scope of Antibodies for Research
1.2 Antibodies for Research Segment by Type
1.2.1 Global Antibodies for Research Market Value Comparison by Type (2023-2029)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Antibodies for Research Segment by Application
1.3.1 Global Antibodies for Research Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Neurobiology
1.3.4 Immunology
1.3.5 Others
1.4 Global Antibodies for Research Market Size Estimates and Forecasts
1.4.1 Global Antibodies for Research Revenue 2018-2029
1.4.2 Global Antibodies for Research Sales 2018-2029
1.4.3 Global Antibodies for Research Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Antibodies for Research Market Competition by Manufacturers
2.1 Global Antibodies for Research Sales Market Share by Manufacturers (2018-2023)
2.2 Global Antibodies for Research Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Antibodies for Research Average Price by Manufacturers (2018-2023)
2.4 Global Antibodies for Research Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Antibodies for Research, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibodies for Research, Product Type & Application
2.7 Antibodies for Research Market Competitive Situation and Trends
2.7.1 Antibodies for Research Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antibodies for Research Players Market Share by Revenue
2.7.3 Global Antibodies for Research Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibodies for Research Retrospective Market Scenario by Region
3.1 Global Antibodies for Research Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Antibodies for Research Global Antibodies for Research Sales by Region: 2018-2029
3.2.1 Global Antibodies for Research Sales by Region: 2018-2023
3.2.2 Global Antibodies for Research Sales by Region: 2024-2029
3.3 Global Antibodies for Research Global Antibodies for Research Revenue by Region: 2018-2029
3.3.1 Global Antibodies for Research Revenue by Region: 2018-2023
3.3.2 Global Antibodies for Research Revenue by Region: 2024-2029
3.4 North America Antibodies for Research Market Facts & Figures by Country
3.4.1 North America Antibodies for Research Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Antibodies for Research Sales by Country (2018-2029)
3.4.3 North America Antibodies for Research Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antibodies for Research Market Facts & Figures by Country
3.5.1 Europe Antibodies for Research Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Antibodies for Research Sales by Country (2018-2029)
3.5.3 Europe Antibodies for Research Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibodies for Research Market Facts & Figures by Country
3.6.1 Asia Pacific Antibodies for Research Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Antibodies for Research Sales by Country (2018-2029)
3.6.3 Asia Pacific Antibodies for Research Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antibodies for Research Market Facts & Figures by Country
3.7.1 Latin America Antibodies for Research Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Antibodies for Research Sales by Country (2018-2029)
3.7.3 Latin America Antibodies for Research Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antibodies for Research Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibodies for Research Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Antibodies for Research Sales by Country (2018-2029)
3.8.3 Middle East and Africa Antibodies for Research Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antibodies for Research Sales by Type (2018-2029)
4.1.1 Global Antibodies for Research Sales by Type (2018-2023)
4.1.2 Global Antibodies for Research Sales by Type (2024-2029)
4.1.3 Global Antibodies for Research Sales Market Share by Type (2018-2029)
4.2 Global Antibodies for Research Revenue by Type (2018-2029)
4.2.1 Global Antibodies for Research Revenue by Type (2018-2023)
4.2.2 Global Antibodies for Research Revenue by Type (2024-2029)
4.2.3 Global Antibodies for Research Revenue Market Share by Type (2018-2029)
4.3 Global Antibodies for Research Price by Type (2018-2029)
5 Segment by Application
5.1 Global Antibodies for Research Sales by Application (2018-2029)
5.1.1 Global Antibodies for Research Sales by Application (2018-2023)
5.1.2 Global Antibodies for Research Sales by Application (2024-2029)
5.1.3 Global Antibodies for Research Sales Market Share by Application (2018-2029)
5.2 Global Antibodies for Research Revenue by Application (2018-2029)
5.2.1 Global Antibodies for Research Revenue by Application (2018-2023)
5.2.2 Global Antibodies for Research Revenue by Application (2024-2029)
5.2.3 Global Antibodies for Research Revenue Market Share by Application (2018-2029)
5.3 Global Antibodies for Research Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Antibodies for Research Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Johnson and Johnson Services
6.2.1 Johnson and Johnson Services Corporation Information
6.2.2 Johnson and Johnson Services Description and Business Overview
6.2.3 Johnson and Johnson Services Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson and Johnson Services Antibodies for Research Product Portfolio
6.2.5 Johnson and Johnson Services Recent Developments/Updates
6.3 Eli Lilly and Company
6.3.1 Eli Lilly and Company Corporation Information
6.3.2 Eli Lilly and Company Description and Business Overview
6.3.3 Eli Lilly and Company Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly and Company Antibodies for Research Product Portfolio
6.3.5 Eli Lilly and Company Recent Developments/Updates
6.4 Bio-Rad Laboratories, Inc
6.4.1 Bio-Rad Laboratories, Inc Corporation Information
6.4.2 Bio-Rad Laboratories, Inc Description and Business Overview
6.4.3 Bio-Rad Laboratories, Inc Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio-Rad Laboratories, Inc Antibodies for Research Product Portfolio
6.4.5 Bio-Rad Laboratories, Inc Recent Developments/Updates
6.5 Cell Signalling Technology
6.5.1 Cell Signalling Technology Corporation Information
6.5.2 Cell Signalling Technology Description and Business Overview
6.5.3 Cell Signalling Technology Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cell Signalling Technology Antibodies for Research Product Portfolio
6.5.5 Cell Signalling Technology Recent Developments/Updates
6.6 PerkinEImer
6.6.1 PerkinEImer Corporation Information
6.6.2 PerkinEImer Description and Business Overview
6.6.3 PerkinEImer Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.6.4 PerkinEImer Antibodies for Research Product Portfolio
6.6.5 PerkinEImer Recent Developments/Updates
6.7 Rockland Immunochemicals
6.6.1 Rockland Immunochemicals Corporation Information
6.6.2 Rockland Immunochemicals Description and Business Overview
6.6.3 Rockland Immunochemicals Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Rockland Immunochemicals Antibodies for Research Product Portfolio
6.7.5 Rockland Immunochemicals Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novartis Antibodies for Research Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 BD
6.9.1 BD Corporation Information
6.9.2 BD Description and Business Overview
6.9.3 BD Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BD Antibodies for Research Product Portfolio
6.9.5 BD Recent Developments/Updates
6.10 Abcam
6.10.1 Abcam Corporation Information
6.10.2 Abcam Description and Business Overview
6.10.3 Abcam Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Abcam Antibodies for Research Product Portfolio
6.10.5 Abcam Recent Developments/Updates
6.11 Kamiya Biomedical
6.11.1 Kamiya Biomedical Corporation Information
6.11.2 Kamiya Biomedical Antibodies for Research Description and Business Overview
6.11.3 Kamiya Biomedical Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Kamiya Biomedical Antibodies for Research Product Portfolio
6.11.5 Kamiya Biomedical Recent Developments/Updates
6.12 AMSBIO
6.12.1 AMSBIO Corporation Information
6.12.2 AMSBIO Antibodies for Research Description and Business Overview
6.12.3 AMSBIO Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.12.4 AMSBIO Antibodies for Research Product Portfolio
6.12.5 AMSBIO Recent Developments/Updates
6.13 Thermo Fisher Scientific
6.13.1 Thermo Fisher Scientific Corporation Information
6.13.2 Thermo Fisher Scientific Antibodies for Research Description and Business Overview
6.13.3 Thermo Fisher Scientific Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Thermo Fisher Scientific Antibodies for Research Product Portfolio
6.13.5 Thermo Fisher Scientific Recent Developments/Updates
6.14 GeneTex
6.14.1 GeneTex Corporation Information
6.14.2 GeneTex Antibodies for Research Description and Business Overview
6.14.3 GeneTex Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.14.4 GeneTex Antibodies for Research Product Portfolio
6.14.5 GeneTex Recent Developments/Updates
6.15 MCE
6.15.1 MCE Corporation Information
6.15.2 MCE Antibodies for Research Description and Business Overview
6.15.3 MCE Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.15.4 MCE Antibodies for Research Product Portfolio
6.15.5 MCE Recent Developments/Updates
6.16 Shanghai Yanmai Biotechnology
6.16.1 Shanghai Yanmai Biotechnology Corporation Information
6.16.2 Shanghai Yanmai Biotechnology Antibodies for Research Description and Business Overview
6.16.3 Shanghai Yanmai Biotechnology Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Shanghai Yanmai Biotechnology Antibodies for Research Product Portfolio
6.16.5 Shanghai Yanmai Biotechnology Recent Developments/Updates
6.17 Shanghai LONG ISLAND Antibody Diagnostica
6.17.1 Shanghai LONG ISLAND Antibody Diagnostica Corporation Information
6.17.2 Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Description and Business Overview
6.17.3 Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Shanghai LONG ISLAND Antibody Diagnostica Antibodies for Research Product Portfolio
6.17.5 Shanghai LONG ISLAND Antibody Diagnostica Recent Developments/Updates
6.18 SUNSHINE GUOJIAN PHARMACEUTICAL
6.18.1 SUNSHINE GUOJIAN PHARMACEUTICAL Corporation Information
6.18.2 SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Description and Business Overview
6.18.3 SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.18.4 SUNSHINE GUOJIAN PHARMACEUTICAL Antibodies for Research Product Portfolio
6.18.5 SUNSHINE GUOJIAN PHARMACEUTICAL Recent Developments/Updates
6.19 Shanghai Junshi Biosciences
6.19.1 Shanghai Junshi Biosciences Corporation Information
6.19.2 Shanghai Junshi Biosciences Antibodies for Research Description and Business Overview
6.19.3 Shanghai Junshi Biosciences Antibodies for Research Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Shanghai Junshi Biosciences Antibodies for Research Product Portfolio
6.19.5 Shanghai Junshi Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibodies for Research Industry Chain Analysis
7.2 Antibodies for Research Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibodies for Research Production Mode & Process
7.4 Antibodies for Research Sales and Marketing
7.4.1 Antibodies for Research Sales Channels
7.4.2 Antibodies for Research Distributors
7.5 Antibodies for Research Customers
8 Antibodies for Research Market Dynamics
8.1 Antibodies for Research Industry Trends
8.2 Antibodies for Research Market Drivers
8.3 Antibodies for Research Market Challenges
8.4 Antibodies for Research Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
